Literature DB >> 19404965

Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.

Caroline Rochas1, Sophie Hillion, Alain Saraux, Rizgar A Mageed, Pierre Youinou, Christophe Jamin, Valérie Devauchelle.   

Abstract

OBJECTIVE: B cells that accumulate in the synovial tissue of rheumatoid arthritis (RA) patients revise their receptors due to coordinate expression of recombination-activating gene 1 (RAG-1) and RAG-2 genes. The aim of this study was to determine the mechanisms that control this re-expression.
METHODS: B cells from healthy control subjects were cocultured with fibroblast-like synoviocytes (FLS) from patients with RA and osteoarthritis (OA). Re-expression of RAG messenger RNA (mRNA) and proteins was analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and indirect immunofluorescence. Activity of RAG enzymes was evaluated by flow cytometry to measure variations in immunoglobulin kappa and lambda light chain expression and by ligation-mediated-PCR to assess specific DNA breaks. Blocking antibodies, short hairpin RNA, and recombinant cytokine were used to identify the molecules involved in RAG re-expression.
RESULTS: RA FLS, but not OA FLS, induced B cells to re-express RAG mRNA and proteins. Enzymes were functional, since the kappa-to-lambda ratios decreased and specific DNA breaks were detectable after coculture with RA FLS. Transmembrane BAFF provided the first signal of RAG re-expression, since its down-regulation in RA FLS prevented RAG gene transcription in B cells. The failure of transmembrane BAFF from OA FLS to induce RAG suggests that a second signal was provided by RA FLS. Interleukin-6 (IL-6) is a candidate, since blockade of its receptors precluded transcription of RAG genes by RA FLS. Unless supplemented with IL-6, OA FLS were unable to induce RAG gene expression in normal B cells.
CONCLUSION: Two independent signals are required for the induction of RAG gene expression in B cells that infiltrate the synovium of patients with RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404965     DOI: 10.1002/art.24498

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells.

Authors:  Yi Yan; Ying-Hua Wang; Betty Diamond
Journal:  J Autoimmun       Date:  2011-12-07       Impact factor: 7.094

2.  Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice.

Authors:  Katalin Kis-Toth; Marianna Radacs; Katalin Olasz; Willem van Eden; Katalin Mikecz; Tibor T Glant
Journal:  Int Immunol       Date:  2012-04-19       Impact factor: 4.823

Review 3.  Cell-cell interactions in rheumatoid arthritis synovium.

Authors:  David A Fox; Alison Gizinski; Rachel Morgan; Steven K Lundy
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

Review 4.  Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 20.543

5.  Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients.

Authors:  Weiqing Huang; Tam D Quach; Cosmin Dascalu; Zheng Liu; Tungming Leung; Miranda Byrne-Steele; Wenjing Pan; Qunying Yang; Jian Han; Martin Lesser; Thomas L Rothstein; Richard Furie; Meggan Mackay; Cynthia Aranow; Anne Davidson
Journal:  JCI Insight       Date:  2018-09-06

6.  Curcumin protects against collagen-induced arthritis via suppression of BAFF production.

Authors:  Gang Huang; Zhizhen Xu; Yan Huang; Xiaojun Duan; Wei Gong; Yan Zhang; Jishan Fan; Fengtian He
Journal:  J Clin Immunol       Date:  2012-11-27       Impact factor: 8.317

7.  B Cell in Autoimmune Diseases.

Authors:  Christiane S Hampe
Journal:  Scientifica (Cairo)       Date:  2012

8.  Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor.

Authors:  Joseph Manetta; Holly Bina; Paul Ryan; Niles Fox; Derrick R Witcher; Kristine Kikly
Journal:  J Inflamm Res       Date:  2014-08-20

Review 9.  Recent advances in neutralizing the IL-6 pathway in arthritis.

Authors:  Charles J Malemud
Journal:  Open Access Rheumatol       Date:  2009-10-05

10.  IL-15 expression on RA synovial fibroblasts promotes B cell survival.

Authors:  Marta Benito-Miguel; Yolanda García-Carmona; Alejandro Balsa; María-Belén Bautista-Caro; Irene Arroyo-Villa; Tatiana Cobo-Ibáñez; María Gema Bonilla-Hernán; Carlos Pérez de Ayala; Paloma Sánchez-Mateos; Emilio Martín-Mola; María-Eugenia Miranda-Carús
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.